What Did You Miss at the Definitive TPD Forum in 2025?
Providing unparalleled networking opportunities with 450+ academic KOLs, start-ups, experienced biotechs, large pharma and leading solution providers, the TPD & Induced Proximity Summit has returned in 2025 with a brand-new and refreshed program, has featured the latest data, the newest innovators and key KOLs in the field including Craig Crews and Ray Deshaies.
This was your ultimate forum to take advantage of key networking opportunities, strategize your therapeutic’s journey to the clinic, and successfully bring PROTACS, molecular glues, and new induced proximity modalities to the standard-of-care for patients in need.
Brand New Companies for 2025
Key Speakers, Companies & Content Tracks in 2025
Discovery Track
This track will showcase novel cutting-edge platforms designed to unlock novel, previously undruggable targets, supported by rich in vitro and cell-based assay data.
Attendees will gain a comprehensive view of the next wave of degraders and actionable insights into accelerating discovery.
This track is for you if: You’re in the screening, hit-finding or hit-to-lead stage.
Speaking Companies Include:
Pre-Clinical Development Track
This track will highlight the most promising degrader candidates advancing through in vivo validation and lead optimization across oncology, inflammatory and CNS indications. Talks will feature mouse model data, giving attendees a clear picture of how TPD is translating into novel cures for unmet diseases areas.
This track is for you if: You’re lead optimizing for oral bioavailability, PKPD, efficacy or safety.
Speaking Companies Include:
Translational & Clinical Development Track
This track will cover the latest translational and clinical data across degraders targeting oncology, autoimmune and CNS indications. Talks will cover how a wide breadth of mechanisms – from PROTACs to DACs and AUTOTACs– are showing meaningful patient outcomes and trailblazing the way for TPD.
This track is for you if: You’re putting together a pre-clinical package or in the clinic.
Speaking Companies Include:
Explore the 2025 Agenda
Hear the latest industry breakthroughs and gain exclusive insights on the TPD innovations during our packed agenda, interactive roundtables, and new CCOs & VC panel discussions.
Partner With Us
Position yourself alongside as the leading solution provider to ensure your brand is at the heart of TPD biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.